Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

摘要

ObjectivesTo evaluate the efficacy and safety of second uterine curettage in lieu of chemotherapy for patients with low-risk, nonmetastatic gestational trophoblastic neoplasia (GTN), and to evaluate if response to second curettage is independent of patient age, World Health Organization (WHO) risk score, registration human chorionic gonadotropin (hCG) level, lesion size and depth of myometrial invasion measured on ultrasound examination.